Search PDMR transactions

Notifier
Name of person with notification obligation
Stig Anders Jacob Lindberg
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Stig Anders Jacob Lindberg
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Oncopeptides AB
Issuer´s LEI code
549300J9WWQ5CBYQ1M77
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Oncopeptides AB SE0009414576 Acquisition 215,000 Quantity 9.2846 SEK 18/02/2022 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Oncopeptides AB SE0009414576 Acquisition 18/02/2022 NASDAQ STOCKHOLM AB 215,000 (Quantity) 9.2846 SEK
Total: 215,000
<< Back